Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis

Nima Ghalehsari, MD, Pragnan Kancharla, MD MBBS, Neil S Nimkar, MD, Anita Mazloom, MD, Farah Ashraf, DO, Angelica Singh, MD, Mendel Goldfinger, MD

Blood (2019) 134 (Supplement_1): 3430.

https://doi.org/10.1182/blood-2019-127625

Published: 2019

Journal Articles

Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

Mariko Ishibashi, PhD, Ryosuke Kinoshita, MD, Koiti Inokuchi, MD PhD Prof., Hiroshi Handa, MD PhD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Yoichi Imai, MD PhD, Norina Hiroike, MD PhD, Junji Tanaka, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Mika Sunakawa, MD, Toshio Asayama, MD, Yasuko Kuribayashi-hamada, MD, Rimpei Morita, MD PhD, Hideto Tamura, MD PhD

Blood (2019) 134 (Supplement_1): 4361.

https://doi.org/10.1182/blood-2019-124635

Published: 2019

Journal Articles

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Yoshiaki Abe, Tetsuya Kobayashi, MD, Kentaro Narita, MD, Hiroki Kobayashi, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 4478.

https://doi.org/10.1182/blood-2018-99-110064

Published: 2018

Journal Articles

Scoring System for Predicting Risk of Relapse in Patients with Multiple Myeloma within Two Years after Stem Cell Transplantation

Beihui Huang, MD, Juan Li, MD, Jin Lu, MD, Yang Xiao, MD, Ying Zhao, MD, Hongming Huang, MD

Blood (2017) 130 (Supplement 1): 4531.

https://doi.org/10.1182/blood.V130.Suppl_1.4531.4531

Published: 2017

Journal Articles

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

Sabarish Ram Ayyappan, MBBS, Vinita Gupta, MD, Akiva Diamond, MD, Brenda Cooper, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Leland Metheny, MD, Hillard M. Lazarus, MD, Stanton L. Gerson, MD, Marcos De Lima, MD, Paolo F. Caimi, MD

Blood (2016) 128 (22): 3611.

https://doi.org/10.1182/blood.V128.22.3611.3611

Published: 2016

Journal Articles

A Predictive Model of Overall Survival (OS) for Patients with Relapsed/Refractory Multiple Myeloma (MM) Enrolling in Phase I Clinical Trials,

Ajay K. Nooka, MD, MPH, FACP, Samatha Muppidi, MD, R. Donald Harvey, PharmD, Jonathan L. Kaufman, MD, Amelia Langston, MD, Colleen Lewis, MSN, Lawrence H. Boise, PhD, Christopher R Flowers, MD, Sagar Lonial, MD

Blood (2011) 118 (21): 3954.

https://doi.org/10.1182/blood.V118.21.3954.3954

Published: 2011

Journal Articles

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

Andrew Hodson, MD, Barbara Bain, FRCPath, MB, Paul Fields, MD, PhD, Graham Talyor, MD

Blood (2010) 116 (21): 4167.

https://doi.org/10.1182/blood.V116.21.4167.4167

Published: 2010

Journal Articles

Incidence, Pattern and Clinical Correlation of Bone Marrow Involvement In Adult T-Cell Leukaemia/Lymphoma (ATLL)

Andrew Hodson, MD, Meenal Gupta, MD, Graham Taylor, MD, Paul Fields, MD, PhD, Jon van Der Walt, Mufaddal Moonim

Blood (2010) 116 (21): 5085.

https://doi.org/10.1182/blood.V116.21.5085.5085

Published: 2010

Journal Articles

Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL)

Andrew Hodson, MD, Silvia Montoto, MD, Naheed Mir, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Kate Cwynarski, MD, PhD, Kirit M Ardeshna, MD, Thurai Kumaran, MD, Estella Matutes, MD, PhD, Graham Talyor, MD, Paul Fields, MD, PhD

Blood (2010) 116 (21): 3961.

https://doi.org/10.1182/blood.V116.21.3961.3961

Published: 2010

Journal Articles

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Steven Schuster, MD, Angela Dispenzieri, M.D., S. Vincent Rajkumar, M.D., Alvaro Moreno Aspitia, Assistant, Professor, of, Medici, Robert Kyle, M.D., Joseph R. Mikhael, MD

Blood (2009) 114 (22): 1828.

https://doi.org/10.1182/blood.V114.22.1828.1828

Published: 2009

Journal Articles

Monoclonal Gammopathy of Undetermined Significance with an IgE Paraprotein.

Robert M. Ayto, MBBS, Christopher Lambert, BMBS, Irvin Lampert, Nina Salooja

Blood (2007) 110 (11): 4744.

https://doi.org/10.1182/blood.V110.11.4744.4744

Published: 2007

Journal Articles

Laboratory Tumor Lysis Syndrome Complicating LBH589 Therapy in a Patient with Acute Myeloid Leukemia.

Anna Kalff, MBBS, Jake Shortt, MBBS, Julia Farr, Roger McLennan, MBBS, Jeffrey W. Scott, Angela Liu, Andrew Spencer, MBBS

Blood (2006) 108 (11): 4554.

https://doi.org/10.1182/blood.V108.11.4554.4554

Published: 2006

NARROW

An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis

Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Scoring System for Predicting Risk of Relapse in Patients with Multiple Myeloma within Two Years after Stem Cell Transplantation

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

A Predictive Model of Overall Survival (OS) for Patients with Relapsed/Refractory Multiple Myeloma (MM) Enrolling in Phase I Clinical Trials,

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

Incidence, Pattern and Clinical Correlation of Bone Marrow Involvement In Adult T-Cell Leukaemia/Lymphoma (ATLL)

Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL)

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Monoclonal Gammopathy of Undetermined Significance with an IgE Paraprotein.

Laboratory Tumor Lysis Syndrome Complicating LBH589 Therapy in a Patient with Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only